Multiplo Tp/HIV Self-Test

NANot yet recruitingINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

December 10, 2025

Conditions
HIV InfectionSyphilis Infection
Interventions
DEVICE

Multiplo TP/HIV Antibody Test

"The Multiplo TP/HIV Antibody Test (MedMira Laboratories Inc., Halifax, NS), \[Multiplo TP/HIV Test\] is a single use, rapid, vertical-flow in vitro qualitative immunoassay for the detection of antibodies to Human Immunodeficiency Virus (HIV) Type 1/Type 2 and Treponema pallidum (Syphilis) in human fingerstick blood. The Multiplo® TP/HIV Test is intended as an aid in the diagnosis of HIV1/2 and Syphilis infections in patients with signs and symptoms of HIV and syphilis. The test is intended for use by trained personnel in medical facilities, clinical laboratories, emergency care situations, and physicians' offices as an in vitro diagnostic device capable of providing results in less than five minutes. The Multiplo TP/HIV Test has not yet sought approval for self-testing. All required pre and post-test counselling guidelines must be followed in each setting in which the Multiplo TP/HIV Test is used. Results are read visually."

Trial Locations (4)

V8W 1M8

Cool Aid Community Health Centre, Victoria

M5B 1J3

Women's Health in Women's Hands, Toronto

M5G 1K2

Maple Leaf Medical Clinic, Toronto

H2L 4P9

Clinique L'actuel Médicale, Montreal

All Listed Sponsors
collaborator

University of Toronto

OTHER

lead

Unity Health Toronto

OTHER

NCT06716450 - Multiplo Tp/HIV Self-Test | Biotech Hunter | Biotech Hunter